DUBLIN--(BUSINESS WIRE)--The "Biomaterials Market by Type and Application - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" report has been added to Research and Markets' offering.
The global biomaterials market is estimated to reach $139 by 2022, growing at a CAGR of 11.8% from 2016 to 2022
Metallic biomaterials segment is expected to contribute significantly to the global market revenue until 2022. North America held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period.
Biomaterials are artificially derived synthetic or natural materials that are used in medical technology to improve the functionality of damaged tissues and organs. These biomaterials are used to interact with biological systems for medical purposes and treatments of cardiovascular, dental, orthopedic, and neurological disorders.
Moreover, biomaterials science can be implemented in various advanced medical technologies such, tissue engineering, plastic surgery, drug delivery devices, and other medical implants. Biomaterial applications are finding prominence in the research on biomed engineering, biomineralization, and biomolecules.
Increase in geriatric population, high prevalence of cardiovascular, neurological, & orthopedic disorders, and heavy funding by government organizations to launch new products, increase awareness regarding the advantages of biomaterials products, increase production of implantable products, and advancements in medical technology are the key drivers of the market. The growth of the market is hindered by factors, such as high cost of biomaterial production, occurrence of inflammatory responses due to compatibility issues, and complications associated with the use of these products.
The report analyzes the biomaterials industry based on type, namely, metallic, polymeric, ceramic, and natural types.
The global biomaterials market size is driven by factors including an increase in geriatric population who are susceptible to diseases, such as cardiovascular, dental, orthopedic, and neurological conditions. Biomaterials are extensively used in hip and knee replacement surgeries. The high demand for implantable devices has boosted the market growth. These implantable devices are widely used in chronic degenerative diseases, such as orthopedic ailments and cardiovascular disorders.
Key Topics Covered:
Chapter: 1 Introduction
Chapter: 2 Executive Summary
Chapter: 3 Market Overview
Chapter: 4 World Biomaterials Market, By Type, 2014-2022
Chapter: 5 World Biomaterials Market, By Application, 2014-2022
Chapter: 6 World Biomaterials Market, By Geography, 2014-2022
Chapter: 7 Company Profiles
- BASF SE
- Bayer AG
- Carpenter Technology Corporation
- Collagen Matrix, Inc.
- Corbion N.V.
- Covalon Technologies Ltd.
- Evonik Industries AG
- Royal DSM
- Victrex plc.
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/83q4tk/biomaterials